1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Pharmacovigilance and Drug Safety Software Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Pharmacovigilance and Drug Safety Software Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rise in Incidences of Adverse Drug Reactions
- 5.1.2 Globalization of Pharmacovigilance
- 5.1.3 Surge in Drug Development Spending
5.2 Market Opportunities
- 5.2.1 Integration of Software with AI, ML, and NLP
5.3 Future Trends
- 5.3.1 Cloud-Based Pharmacovigilance, Drug Safety Software
5.4 Impact of Drivers and Restraints
6. North America Pharmacovigilance and Drug Safety Software Market Regional Analysis
6.1 North America Pharmacovigilance and Drug Safety Software Market Overview
6.2 North America Pharmacovigilance and Drug Safety Software Market Revenue 2017-2027 (US$ Million)
6.3 North America Pharmacovigilance and Drug Safety Software Market Forecast Analysis
7. North America Pharmacovigilance and Drug Safety Software Market Analysis – by Software Type
7.1 Adverse Event Reporting Software
- 7.1.1 Overview
- 7.1.2 Adverse Event Reporting Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Drug Safety Audits Software
- 7.2.1 Overview
- 7.2.2 Drug Safety Audits Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Issue Tracking Software
- 7.3.1 Overview
- 7.3.2 Issue Tracking Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Fully Integrated Software
- 7.4.1 Overview
- 7.4.2 Fully Integrated Software: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Pharmacovigilance and Drug Safety Software Market Analysis – by Delivery Mode
8.1 On-premise
- 8.1.1 Overview
- 8.1.2 On-premise: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Cloud-based
- 8.2.1 Overview
- 8.2.2 Cloud-based: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Pharmacovigilance and Drug Safety Software Market Analysis – by End User
9.1 Pharmaceutical and Biotech Companies
- 9.1.1 Overview
- 9.1.2 Cloud-based: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Contract Research Organizations
- 9.2.1 Overview
- 9.2.2 Cloud-based: North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Pharmacovigilance and Drug Safety Software Market – North America Analysis
10.1 North America
- 10.1.1 North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Pharmacovigilance and Drug Safety Software Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Software Type
- 10.1.1.1.2 US: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Delivery Mode
- 10.1.1.1.3 US: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Software Type
- 10.1.1.2.2 Canada: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Delivery Mode
- 10.1.1.2.3 Canada: North America Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Pharmacovigilance and Drug Safety Software Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Software Type
- 10.1.1.3.2 Mexico : North America Pharmacovigilance and Drug Safety Software Market Breakdown, by Delivery Mode
- 10.1.1.3.3 Mexico : North America Pharmacovigilance and Drug Safety Software Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Pharmacovigilance and Drug Safety Software Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Veeva Systems
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 IQVIA Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Ennov
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AB Cube
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 United Biosource LLC
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ArisGlobal LLC
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Sparta Systems
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Oracle Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Sarjen Systems Pvt. Ltd
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 EXTEDO
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Online Business Applications, Inc.
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Pharmacovigilance and Drug Safety Software Market
